These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9623398)

  • 21. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
    Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
    Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvillar enzymes in amniotic fluid. Considerations for the prenatal diagnosis of cystic fibrosis.
    Carey WF; Pollard AC
    Med J Aust; 1986 Jan; 144(2):68-71. PubMed ID: 2417095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cystic fibrosis: a four year regional experience.
    Roberts G; Stanfield M; Black A; Redmond A
    Arch Dis Child; 1988 Dec; 63(12):1438-43. PubMed ID: 3232990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.
    Chatfield S; Owen G; Ryley HC; Williams J; Alfaham M; Goodchild MC; Weller P
    Arch Dis Child; 1991 Jan; 66(1 Spec No):29-33. PubMed ID: 1996888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
    Hammond KB; Abman SH; Sokol RJ; Accurso FJ
    N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of DNA probes for the prenatal diagnosis of cystic fibrosis.
    Dry PJ; Wake S; Robertson CF; Colley P; Sheffield LJ
    Med J Aust; 1989 Aug; 151(3):131, 133-6. PubMed ID: 2569157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of cystic fibrosis by chorionic villus sampling using 12 polymorphic deoxyribonucleic acid markers.
    Nugent CE; Gravius T; Green P; Larsen JW; MacMillin MD; Donis-Keller H
    Obstet Gynecol; 1988 Feb; 71(2):213-5. PubMed ID: 3422111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of cystic fibrosis in Scotland calculated from heterozygote frequencies.
    Brock DJ; Gilfillan A; Holloway S
    Clin Genet; 1998 Jan; 53(1):47-9. PubMed ID: 9550361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular screening of cystic fibrosis patients.
    Fellowes AP; Murphy JM; Wesley AW; Dawson KP; George PM
    N Z Med J; 1991 Oct; 104(921):415-6. PubMed ID: 1923090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
    J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between carrier screening and incidence of cystic fibrosis.
    Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
    JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study.
    Sims EJ; Mugford M; Clark A; Aitken D; McCormick J; Mehta G; Mehta A;
    Lancet; 2007 Apr; 369(9568):1187-95. PubMed ID: 17416263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn bloodspot screening for cystic fibrosis: What do antenatal and postnatal women know about cystic fibrosis?
    Fitzgerald C; Linnane B; Heery E; Conneally N; George S; Fitzpatrick P
    J Cyst Fibros; 2016 Jul; 15(4):436-42. PubMed ID: 26708264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis in Ontario.
    Sturgess JM; Czegledy-Nagy E; Corey M; Thompson MW
    Am J Med Genet; 1985 Oct; 22(2):383-93. PubMed ID: 4050869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal diagnosis of cystic fibrosis in a Turkish family.
    Yilmaz E; Ozgüç M; Coşkun T; Beksaç S; Cakar N; Ayter S; Ozalp I
    Turk J Pediatr; 1991; 33(2):79-84. PubMed ID: 1844185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-trimester fetal screening of cystic fibrosis in low-risk population.
    Brambati B; Tului L; Fattore S
    Lancet; 1993 Sep; 342(8871):624. PubMed ID: 8102758
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations.
    DeMarchi JM; Beaudet AL; Caskey CT; Richards CS
    Arch Pathol Lab Med; 1994 Jan; 118(1):26-32. PubMed ID: 8285831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of cystic fibrosis in London and South East England before and after the introduction of newborn screening.
    Lim MT; Wallis C; Price JF; Carr SB; Chavasse RJ; Shankar A; Seddon P; Balfour-Lynn IM
    Arch Dis Child; 2014 Mar; 99(3):197-202. PubMed ID: 24243928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.